Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
16.50
-1.02 (-5.82%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $1.01 billion as of July 31, 2026. Its market cap has increased by 110.58% in one year.
Market Cap
1.01B
Enterprise Value
664.56M
1-Year Change
110.58%
Ranking
Category
Stock Price
$16.50
ChartMarket Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $1.01B, an increase of 22.26%. That is a compound annual growth rate of 3.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.01B | 65.85% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 1.09B |
| Wave Life Sciences | 1.09B |
| Alpha Tau Medical | 1.06B |
| Alto Neuroscience | 1.05B |
| Inventiva | 1.03B |
| EyePoint | 1.03B |
| Lexicon Pharmaceuticals | 1.03B |
| Olema Pharmaceuticals | 1.00B |